天津医药 ›› 2017, Vol. 45 ›› Issue (11): 1124-1129.doi: 10.11958/20171128

• 专题-心肌梗死 • 上一篇    下一篇

中国急性心肌梗死救治新进展及挑战

刘寅,高静   

  1. 天津市胸科医院,天津市心血管病研究所
  • 收稿日期:2017-10-20 修回日期:2017-10-26 出版日期:2017-11-15 发布日期:2017-11-15
  • 通讯作者: 刘寅 E-mail:liuyin2088@163.com
  • 基金资助:
    天津市科技重大专项与工程项目(16ZXMJSY00150);天津市卫生行业重点攻关项目(16KG131)

Progress and current challenges in treatment of acute myocardial infarction in China

LIU Yin, GAO Jing   

  1. Tianjin Chest Hospital, Tianjin Cardiovascular Institute
  • Received:2017-10-20 Revised:2017-10-26 Published:2017-11-15 Online:2017-11-15

摘要: 急性心肌梗死(AMI)作为冠心病急性事件(慢病急性期)具有高发病、高致死致残、高花费的特点,是心血管疾病防治的重中之重,也是降低心血管病死亡率的关键控制点。近些年,AMI 治疗策略的不断优化以及新型治疗手段的应用,依据近期的大型临床试验,国内外不断更新 AMI 的治疗指南以便更好地指导临床工作。本文分享了AMI 救治领域先进的技术和理念,展望新的学术前沿,对国内外最新治疗指南和最新研究进展进行了简析。

关键词: 心肌梗死, 血管成形术, 经腔, 经皮冠状动脉, 休克, 心原性, 首次医疗接触

Abstract: With high incidence, high mortality, high disability and high medical cost, acute myocardial infarction(AMI), the most acute events of coronary heart disease (or the acute exacerbation of chronic coronary disease), becomes the priority in preventing and treating cardiovascular diseases and the vital point of reducing cardiovascular mortality. In recent years, with the continuous improvement of AMI treatment strategy and the application of new treatment methods, based on the recent large-scale clinical trials, the guideline of treating AMI are constantly updated at home and abroad to better guide clinical work. In this paper, we share the advanced technologies and concepts in treating AMI, and look forward to the new academic frontiers. We aim to make a brief analysis of the latest treatment guidelines and the latest research progress.

Key words: myocardial infarction, angioplasty, transluminal, percutaneous coronary, shock, cardiogenic, first medical contact

中图分类号: